NCT07327788 2026-01-13
QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT
Nanfang Hospital, Southern Medical University
Phase 2 Recruiting
Clinical Trials
23 trialsNCT06427005 2025-01-22
Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC
West China Hospital
Phase 2 Recruiting
NCT06665087 2024-10-30
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
Fudan University
Phase 2 Not yet recruiting
NCT06652412 2024-10-28
CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC
Fudan University
Phase 2 Not yet recruiting
NCT05628038 2024-10-01
TORCH-R
Fudan University
Phase 2 Recruiting
NCT05435313 2024-01-17
Fruquintinib Combined With Tislelizumab and HAIC in Patients With Advanced Colorectal Liver Metastases Cancer Who Failed Standard Therapy
Fudan University
Phase 2 Unknown
NCT05160896 2023-06-08
SALIRI Based Regimen as First-line Treatment for Advanced Metastatic Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Unknown
NCT02562599 2022-02-22
Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin
Hubei Cancer Hospital
Phase 2 Completed
NCT04582981 2021-10-26
Fruquintinib and Raltitrexed Versus Fruquintinib Monotherapy in Advanced Colorectal Cancer
Fudan University
Phase 2 Unknown
NCT03126071 2021-08-30
Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT04241731 2021-08-30
A Study of Cetuximab Plus Raltitrexed for Maintenance Treatment in Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Phase 2 Unknown
NCT03585530 2021-04-06
Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus
Huai'an First People's Hospital
Phase 2 Unknown
NCT01481545 2021-02-03
BRANCH
National Cancer Institute, Naples
Phase 2 Completed
NCT04499586 2020-08-05
A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal Cancer
Fudan University
Phase 2 Unknown
NCT03813641 2019-09-09
RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study)
Shenzhen People's Hospital
Phase 2 Unknown
NCT03823079 2019-01-30
Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia
Fudan University
Phase 2 Unknown
NCT02618356 2017-10-02
Combined Use of Raltitrexed and S-1 as Treatment for Patients With Metastasizing Colorectal Cancer
Fudan University
Phase 2 Unknown
NCT03053167 2017-02-14
Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer Patients
China Medical University, China
Phase 2 Unknown
NCT02723253 2016-03-30
Concurrent Chemoradiation With Concomitant Boost In Locally Advanced Rectal Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 2 Completed
NCT02376452 2015-03-03
Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients
Fudan University
Phase 2 Unknown
NCT02072317 2014-02-26
Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer
Fudan University
Phase 2 Unknown
NCT01836120 2013-04-19
A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer
Hebei Tumor Hospital
Phase 2 Unknown
NCT01732380 2012-11-22
A Phase-II Study Of Raltitrexed/Oxaliplatin Plus Radiotherapy Versus Radiotherapy In Subjects With Inoperable Esophageal Cancer
The First People's Hospital of Lianyungang
Phase 2 Unknown